GlassScriptPhysician profile
Somayeh D Azimi
NPI 1356876999
$1,554.02
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.13 · 2022: $285 · 2023: $467 · 2024: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.03 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $215.28 | 2024 | Camzyos |
| Corcept Therapeutics | $198.20 | 2024 | Korlym |
| Lilly USA, LLC | $173.96 | 2021-2024 | Mounjaro, Zepbound |
| Beta Bionics, INC. | $146.92 | 2023 | Ilet Bionic Pancreas |
| Alexion Pharmaceuticals, INC. | $100.80 | 2024 | Strensiq |
| Tandem Diabetes Care, INC. | $99.55 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $69.90 | 2022-2023 | |
| Amgen INC. | $53.17 | 2024 | Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $40.98 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $27.50 | 2022 | |
| Mannkind Corporation | $24.59 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.57 | 2023 | |
| Medtronic, INC. | $17.48 | 2023 | Minimed 780g |
| Dexcom, INC. | $16.76 | 2024 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $16.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Somayeh Azimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.